PhD Degree Program in Pharmacological Sciences

 

Admission 2022

On 12 April 2022 the call for admission to the PhD-Programme in Pharmacological Sciences (38th series) at the University of Padova has been published. 

CALL FOR ADMISSION TO PHD COURSES FOR THE XXXVIII CYCLE
Pharmacological Sciences PhD Course 38° series 2022/23 
Technical guidelines for the submission of the application form for PhD Courses, 38th series

Important dates and deadlines
13 May 2022 (13:00): application deadline
18 May 2022 (13:00): deadline for sending reference letters from referee.

Within 10 JUNE 2022 the evaluating Commission will publish the results of the evaluation of the qualifications in this same website.

Oral examination: 16 JUNE 2022 09:00 - The exam may continue: 17/06/2022 - Applicants who have requested it in the application form will take the oral exam via remote interview using the ZOOM videoconference tool.

1 October 2022: starting date of the PhD-Programme in Pharmacologicla Sciences (38th cycle)

Results of the evaluation of the qualifications
to access the results, the candidate has to insert the password received when he submitted the application

Oral examination List
to access the list, the candidate has to insert the password received when he submitted the application


38° series PhD Projects: 

-Role of multiproteic complex NLRP3 inflammosome and dietary habits in central and peripheral inflammatory processes in Parkinson disease;
-Development of innovative therapies for chemotherapy-treated prostate cancer;
-Development of senolytics of natural origin for anti-aging therapy;
-Targeting melatonin receptors for neuropsychiatric disorders;
-Pharmacological modulation of age-related vascular pathologies;
-Study of metabolic reprogramming and identification of innovative pharmacological targets in chemotherapy resistance;
-Study of possible hormonal implications in Sars-CoV-2 virus infection and disease progression;
-Risk assessment of combined chemical exposures;
-Long COVID-19 asymptomatic or pauci-symptomatic and biological aging;
-Correlation Between Concentration at the Effector Site of Ketamine (Calculated With DOMINO Pump) and Bispectral Index Values During General Anaesthesia for Breast Surgery; 
 -Sex differences in immune checkpoint expression and release by human endothelial cells and monocyte-derived macrophages: implications for combined personalized therapies;
 -Investigating novel immunotherapy strategies to treat liver cancer;
-Surveillance of healthcare workers for SARS-CoV-2 infection and testing of a clinical follow-up model;
 -Role of Toll like receptor 4 in opioid-induced microglia activation and tolerance.

Training the next generation Talents UNIPhD Programme - Pharmacological Sciences


Planned Teaching activities:

First year
- Course on "Information Literacy in Pharmacological Sciences"
- Course on "Bio-Statistics"
Second year
- Course on “Academic English for PhD Students”, at Centro Linguistico di Ateneo
- "Advanced Pharmacology" course consisting of 5 modules each: 1) Pharmacokinetics 2) Clinical biochemistry 3) Methods in Molecular Pharmacology 4) Application aspects of clinical research methodology 5) Neuropharmacology.
Third year
- Teaching of "Communicating Science Effectively".
Several seminars (approximately once a month) will also be organized and held by English-speaking scientists.
PhD students are required to attend at least 70% of the training activities offered and pass the evaluation test.


The mission of the 3 years PhD Course in Pharmacological Sciences is to prepare new young generation of scientists with a solid background in the field of Molecular Pharmacology, Clinical Pharmacology, Pharmacoepidemiology and Toxicology. To this purposes the PhD scholar program is organized in two parallel curricula:

- Molecular and Cellular Pharmacology
- Pharmacology, Toxicology and Therapeutics

***************************************************************************************************

Research lines - Molecular and Cellular Pharmacology

- Neuro-degenerative disorders: molecular mechanisms, genetics, and studies of therapeutic interventions
- Autonomic nervous system on bronchial function, new pharmacological agents
- Enteric nervous system and immune system, search for therapeutic targets
- Cardiovascular diseases, aging, gender and pharmacological responses
- Antitumoral compounds and mechanisms in drug resistance
- Metabolomics and lipidomics studies to the identification of new drug targets
- Immune system and search for molecular pharmacological targets
- Pharmacological modulation of chronic inflammatory diseases
- Medicinal plants as source of pharmacological agents
- Phenotyping/genotyping and therapeutic monitoring to develop new diagnostic screening tests
- Pharmacokinetic studies in healthy and disease

Research lines - Pharmacology, Toxicology and Therapeutics

- Critical care therapy. Pain therapies, both intensive and hyperbaric
- Risk prevention and occupational medicine
- Airway inflammation induced by inhaled pollutants
- Environmental toxicology xenobiotics in the urban water cycle
- Development of new environmentally friendly and species-selective pesticides
- Clinical pharmacology and  therapeutic drug monitoring
- Pharmacoepidemiology
- Pharmacoeconomics
- Pharmacovigilance

Students will choose a research project as proposed by members of the teaching staff involved in the Course and they will be supervised by an experienced tutor, with the possibility to add an external tutor.

The PhD programme offers interdisciplinary seminars, and additional training in presentation seminars and workshops ithus preparing doctoral candidates for work in international and multidisciplinary environments.

At the end of three years, students are required to present the PhD thesis describing their experimental work, which will be assessed by a commission of experts. The final dissertation will confer the title of Research Doctor, or Doctor Europaeus if special conditions are met (thesis written in English, research work in another European country for a minimum of 3 months and dissertation at international examination panel).

Contacts:

Nicola Ferri, PhD director, Department of Pharmacological and Pharmaceutical Sciences, University of Padova. Via Marzolo, 5- 35131 Padova, Italy

e-mail nicola.ferri@unipd.it

Daniela Strafella, PhD secretary, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo, 5, 35131 Padova, Italy
e-mail: daniela.strafella@unipd.it

Call and Admission (37 series)

Calls and Admissions (36th series)

 

*****************************************************************************************************************************************************
Project CO-Fund 2019
UNIPhD: University of Padova PhD Programme - Eight Century Legacy of Frontier Research and Societal Impact

The PhD Course offers 2 scientific course related to the 2 research topic:

- Topic 1: Biostatistics and Clinic Epidemiology (24 hours) 
- Topic 2: Advanced pharmacology (50 hours)
(optional: The PhD students are required to attend at least 70% of training activities offered and pass the evaluation test)

****************************************************************************************************************************************************